Large Cap Archives - Page 182 of 437

1 minute read

AbbVie Raises Annual Profit Outlook As Newer Immunology Drugs Help Cushion Struggling Humira Sales

By Vandana Singh

October 27, 9:56 AM

AbbVie Inc (NYSE: ABBV) has reported Q3 adjusted EPS of $2.95, down 19.4% Y/Y, beating the consensus of $2.88.

ABBV

1 minute read

Why Agriculture Company Corteva’s Shares Are Slipping Today

By Lekha Gupta

October 27, 9:54 AM

Corteva Inc (NYSE: CTVA) shares are trading lower by around 2% after it reported weak

CTVA

2 minute read

Oil and Gas Giant Exxon’s Q3 Profits Slump To $9.1B, Still Raises Annual Outlook

By Vandana Singh

October 27, 9:40 AM

Exxon Mobil Corp's (NYSE: XOM) reported Q3 FY23 adjusted net profit of $9.12 billion, or $2.27 per share, down from 18.682 billion, or $4.45 per share, a year earlier. Analyst estimates stand at $2.37.

PXD

1 minute read

Weight Loss Drugs Like Wegovy Would Not Impact Business – Healthcare Companies Tell Investors

By Vandana Singh

October 27, 7:51 AM

Novo Nordisk A/S (NYSE: NVO) investors and analysts eagerly await the company's third-quarter results, hoping for clarity on when supply limitations for its weight-loss drug, Wegovy, in the U.S.

LLY

2 minute read

Chevron Q3 Results: Earnings Miss On Weak Upstream Performance, Lower Commodity Prices Curbs Sales

By Lekha Gupta

October 27, 7:50 AM

Oil giant Chevron Corp (NYSE: CVX) reported Q3 FY23 total revenues and other income of $54.1 billion, beating the

CVX

2 minute read

Sanofi Goes The Rival Way: Plans Separation Of Consumer Healthcare Unit

By Vandana Singh

October 27, 7:44 AM

Sanofi SA (NASDAQ: SNY) plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment in its drug-development pipeline and cut costs.

SNY